Switch to:
Also traded in: Germany, Mexico

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.03
MD's Cash-to-Debt is ranked lower than
91% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 0.48 vs. MD: 0.03 )
Ranked among companies with meaningful Cash-to-Debt only.
MD' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01  Med: 0.61 Max: N/A
Current: 0.03
Equity-to-Asset 0.51
MD's Equity-to-Asset is ranked higher than
55% of the 255 Companies
in the Global Medical Care industry.

( Industry Median: 0.48 vs. MD: 0.51 )
Ranked among companies with meaningful Equity-to-Asset only.
MD' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.5  Med: 0.76 Max: 0.91
Current: 0.51
0.5
0.91
Interest Coverage 8.34
MD's Interest Coverage is ranked higher than
50% of the 216 Companies
in the Global Medical Care industry.

( Industry Median: 8.41 vs. MD: 8.34 )
Ranked among companies with meaningful Interest Coverage only.
MD' s Interest Coverage Range Over the Past 10 Years
Min: 8.34  Med: 90.58 Max: 294.93
Current: 8.34
8.34
294.93
Piotroski F-Score: 3
Altman Z-Score: 2.68
Beneish M-Score: -2.57
WACC vs ROIC
3.26%
8.27%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 16.95
MD's Operating Margin % is ranked higher than
80% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 7.34 vs. MD: 16.95 )
Ranked among companies with meaningful Operating Margin % only.
MD' s Operating Margin % Range Over the Past 10 Years
Min: 16.95  Med: 21.89 Max: 24.07
Current: 16.95
16.95
24.07
Net Margin % 9.54
MD's Net Margin % is ranked higher than
73% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 4.40 vs. MD: 9.54 )
Ranked among companies with meaningful Net Margin % only.
MD' s Net Margin % Range Over the Past 10 Years
Min: 9.54  Med: 13.46 Max: 15.84
Current: 9.54
9.54
15.84
ROE % 11.80
MD's ROE % is ranked higher than
61% of the 243 Companies
in the Global Medical Care industry.

( Industry Median: 9.35 vs. MD: 11.80 )
Ranked among companies with meaningful ROE % only.
MD' s ROE % Range Over the Past 10 Years
Min: 11.8  Med: 14.04 Max: 17.59
Current: 11.8
11.8
17.59
ROA % 6.11
MD's ROA % is ranked higher than
65% of the 263 Companies
in the Global Medical Care industry.

( Industry Median: 3.85 vs. MD: 6.11 )
Ranked among companies with meaningful ROA % only.
MD' s ROA % Range Over the Past 10 Years
Min: 6.11  Med: 9.93 Max: 12.09
Current: 6.11
6.11
12.09
ROC (Joel Greenblatt) % 221.37
MD's ROC (Joel Greenblatt) % is ranked higher than
95% of the 263 Companies
in the Global Medical Care industry.

( Industry Median: 16.07 vs. MD: 221.37 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
MD' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 221.37  Med: 621.53 Max: 755.09
Current: 221.37
221.37
755.09
3-Year Revenue Growth Rate 17.00
MD's 3-Year Revenue Growth Rate is ranked higher than
80% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 8.00 vs. MD: 17.00 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
MD' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 6.9  Med: 16.7 Max: 45
Current: 17
6.9
45
3-Year EBITDA Growth Rate 13.50
MD's 3-Year EBITDA Growth Rate is ranked higher than
67% of the 167 Companies
in the Global Medical Care industry.

( Industry Median: 8.00 vs. MD: 13.50 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
MD' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -1.4  Med: 13.4 Max: 53.2
Current: 13.5
-1.4
53.2
3-Year EPS without NRI Growth Rate 7.90
MD's 3-Year EPS without NRI Growth Rate is ranked higher than
51% of the 145 Companies
in the Global Medical Care industry.

( Industry Median: 7.50 vs. MD: 7.90 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
MD' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -20.2  Med: 13.6 Max: 71.5
Current: 7.9
-20.2
71.5
GuruFocus has detected 5 Warning Signs with Mednax Inc $MD.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» MD's 30-Y Financials

Financials (Next Earnings Date: 2017-10-27 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2016

MD Guru Trades in Q2 2016

Pioneer Investments 315,383 sh (+20.14%)
Vanguard Health Care Fund 805,600 sh (unchged)
Ray Dalio Sold Out
Jeremy Grantham Sold Out
Joel Greenblatt Sold Out
Columbia Wanger 972,106 sh (-6.68%)
Mariko Gordon 43,087 sh (-18.38%)
Jim Simons 252,200 sh (-42.89%)
» More
Q3 2016

MD Guru Trades in Q3 2016

First Pacific Advisors 23,570 sh (New)
Vanguard Health Care Fund 805,600 sh (unchged)
Mariko Gordon Sold Out
Jim Simons Sold Out
Columbia Wanger 847,522 sh (-12.82%)
Pioneer Investments 134,446 sh (-57.37%)
» More
Q4 2016

MD Guru Trades in Q4 2016

Joel Greenblatt 3,834 sh (New)
First Pacific Advisors 36,570 sh (+55.15%)
Vanguard Health Care Fund Sold Out
Columbia Wanger 792,941 sh (-6.44%)
Pioneer Investments 105,515 sh (-21.52%)
» More
Q1 2017

MD Guru Trades in Q1 2017

Joel Greenblatt 111,724 sh (+2814.03%)
First Pacific Advisors 36,570 sh (unchged)
Pioneer Investments Sold Out
Columbia Wanger 670,130 sh (-15.49%)
» More
» Details

Insider Trades

Latest Guru Trades with MD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 621498    SIC: 8093
Compare:NAS:ACHC, NYSE:HLS, NYSE:EVHC, NAS:WOOF, NYSE:CHE, NAS:LPNT, NYSE:SEM, NAS:AMED, NYSE:THC, NYSE:AMN, NAS:TVTY, NAS:LHCG, NYSE:CYH, NAS:SGRY, NAS:AFAM, NYSE:USPH, NAS:PRSC, NAS:ADUS, NAS:BIOS, NYSE:AAC » details
Traded in other countries:PDC.Germany, MD.Mexico,
Headquarter Location:USA
Mednax Inc is a provider of physician services including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric sub-specialty care.

Mednax Inc was incorporated in Florida in 2007 and is the successor to Pediatrix Medical Group, Inc., which was incorporated in Florida in 1979. The Company is a provider of physician services including Neonatal Care, Maternal-fetal Care, Pediatric Cardiology Care, Other Pediatric Subspecialty Care and Anesthesia Care. The Company's national network comprised over 3,600 affiliated physicians, including over 1,130 physicians who provide neonatal clinical care, in 35 states and Puerto Rico, within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. The Company's network includes other pediatric subspecialists, including over 150 physicians providing pediatric intensive care, 130 physicians providing pediatric cardiology care, 115 physicians providing hospital-based pediatric care and 20 physicians providing pediatric surgical care. Its network includes pediatric intensivists, who are hospital-based pediatricians with additional education and training in caring for critically ill or injured children and adolescents, and pediatric hospitalists, who are hospital-based pediatricians specializing in inpatient care and management of acutely ill children. The Company faces competition from hospital-based practices nationally with other health services companies and physician groups for hospital contracts and qualified physicians. The Company is registered with the United States Patent and Trademark Office the service marks MEDNAX National Medical Group and Design, Pediatrix Medical Group and Design, Obstetrix Medical Group and Design, American Anesthesiology and Design, BabySteps, the Baby Design, Quality Steps, Quantum Clinical Navigation System, iNewborn, NEO Conference and Design, MedData and vRad, among others.

Top Ranked Articles about Mednax Inc

A Deep Analysis of 6 Five-Star Companies These companies have maintained a 5-star predictability rank for the past 5 years
Among U.S. companies, six have maintained a GuruFocus Business Predictability Rank of five stars year over year since June 2012: Jack Henry & Associates Inc. (NASDAQ:JKHY), Mednax Inc. (NYSE:MD), Mesa Laboratories Inc. (NASDAQ:MLAB), Rollins Inc. (NYSE:ROL), Tyler Technologies Inc. (NYSE:TYL) and World Acceptance Corp. (NASDAQ:WRLD). Read more...

Ratios

vs
industry
vs
history
PE Ratio 17.16
MD's PE Ratio is ranked higher than
75% of the 201 Companies
in the Global Medical Care industry.

( Industry Median: 26.05 vs. MD: 17.16 )
Ranked among companies with meaningful PE Ratio only.
MD' s PE Ratio Range Over the Past 10 Years
Min: 6.95  Med: 17.94 Max: 25.04
Current: 17.16
6.95
25.04
Forward PE Ratio 15.55
MD's Forward PE Ratio is ranked higher than
74% of the 62 Companies
in the Global Medical Care industry.

( Industry Median: 21.05 vs. MD: 15.55 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 17.16
MD's PE Ratio without NRI is ranked higher than
77% of the 197 Companies
in the Global Medical Care industry.

( Industry Median: 26.57 vs. MD: 17.16 )
Ranked among companies with meaningful PE Ratio without NRI only.
MD' s PE Ratio without NRI Range Over the Past 10 Years
Min: 8.01  Med: 18.05 Max: 25.52
Current: 17.16
8.01
25.52
Price-to-Owner-Earnings 13.48
MD's Price-to-Owner-Earnings is ranked higher than
79% of the 106 Companies
in the Global Medical Care industry.

( Industry Median: 27.37 vs. MD: 13.48 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
MD' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 5.51  Med: 15.89 Max: 23.37
Current: 13.48
5.51
23.37
PB Ratio 1.98
MD's PB Ratio is ranked higher than
61% of the 242 Companies
in the Global Medical Care industry.

( Industry Median: 2.54 vs. MD: 1.98 )
Ranked among companies with meaningful PB Ratio only.
MD' s PB Ratio Range Over the Past 10 Years
Min: 1.23  Med: 2.3 Max: 3.59
Current: 1.98
1.23
3.59
PS Ratio 1.65
MD's PS Ratio is ranked lower than
52% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 1.69 vs. MD: 1.65 )
Ranked among companies with meaningful PS Ratio only.
MD' s PS Ratio Range Over the Past 10 Years
Min: 1.12  Med: 2.28 Max: 3.84
Current: 1.65
1.12
3.84
Price-to-Free-Cash-Flow 12.92
MD's Price-to-Free-Cash-Flow is ranked higher than
77% of the 116 Companies
in the Global Medical Care industry.

( Industry Median: 24.30 vs. MD: 12.92 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
MD' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 6.34  Med: 14.76 Max: 20.82
Current: 12.92
6.34
20.82
Price-to-Operating-Cash-Flow 11.77
MD's Price-to-Operating-Cash-Flow is ranked higher than
62% of the 167 Companies
in the Global Medical Care industry.

( Industry Median: 15.16 vs. MD: 11.77 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
MD' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.83  Med: 13.73 Max: 19.76
Current: 11.77
5.83
19.76
EV-to-EBIT 12.91
MD's EV-to-EBIT is ranked higher than
77% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 20.05 vs. MD: 12.91 )
Ranked among companies with meaningful EV-to-EBIT only.
MD' s EV-to-EBIT Range Over the Past 10 Years
Min: 5.2  Med: 11.8 Max: 16.9
Current: 12.91
5.2
16.9
EV-to-EBITDA 11.00
MD's EV-to-EBITDA is ranked higher than
71% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 15.41 vs. MD: 11.00 )
Ranked among companies with meaningful EV-to-EBITDA only.
MD' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5  Med: 10.9 Max: 15.4
Current: 11
5
15.4
PEG Ratio 1.26
MD's PEG Ratio is ranked higher than
79% of the 98 Companies
in the Global Medical Care industry.

( Industry Median: 3.06 vs. MD: 1.26 )
Ranked among companies with meaningful PEG Ratio only.
MD' s PEG Ratio Range Over the Past 10 Years
Min: 0.62  Med: 1.32 Max: 2.08
Current: 1.26
0.62
2.08
Shiller PE Ratio 21.30
MD's Shiller PE Ratio is ranked higher than
65% of the 51 Companies
in the Global Medical Care industry.

( Industry Median: 29.00 vs. MD: 21.30 )
Ranked among companies with meaningful Shiller PE Ratio only.
MD' s Shiller PE Ratio Range Over the Past 10 Years
Min: 13.06  Med: 26.18 Max: 42.09
Current: 21.3
13.06
42.09
Current Ratio 1.71
MD's Current Ratio is ranked higher than
63% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 1.32 vs. MD: 1.71 )
Ranked among companies with meaningful Current Ratio only.
MD' s Current Ratio Range Over the Past 10 Years
Min: 0.77  Med: 1.39 Max: 11.34
Current: 1.71
0.77
11.34
Quick Ratio 1.71
MD's Quick Ratio is ranked higher than
67% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 1.25 vs. MD: 1.71 )
Ranked among companies with meaningful Quick Ratio only.
MD' s Quick Ratio Range Over the Past 10 Years
Min: 0.77  Med: 1.39 Max: 11.34
Current: 1.71
0.77
11.34
Days Sales Outstanding 54.50
MD's Days Sales Outstanding is ranked lower than
67% of the 215 Companies
in the Global Medical Care industry.

( Industry Median: 40.40 vs. MD: 54.50 )
Ranked among companies with meaningful Days Sales Outstanding only.
MD' s Days Sales Outstanding Range Over the Past 10 Years
Min: 46.59  Med: 52.83 Max: 58.39
Current: 54.5
46.59
58.39
Days Payable 3.91
MD's Days Payable is ranked lower than
96% of the 160 Companies
in the Global Medical Care industry.

( Industry Median: 44.51 vs. MD: 3.91 )
Ranked among companies with meaningful Days Payable only.
MD' s Days Payable Range Over the Past 10 Years
Min: 3.59  Med: 4.52 Max: 7.33
Current: 3.91
3.59
7.33

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio 2.50
MD's 3-Year Average Share Buyback Ratio is ranked higher than
89% of the 141 Companies
in the Global Medical Care industry.

( Industry Median: -2.20 vs. MD: 2.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
MD' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -17.5  Med: -1.65 Max: 3.4
Current: 2.5
-17.5
3.4

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 0.73
MD's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
89% of the 97 Companies
in the Global Medical Care industry.

( Industry Median: 1.97 vs. MD: 0.73 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
MD' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.46  Med: 1.02 Max: 3.84
Current: 0.73
0.46
3.84
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.05
MD's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
78% of the 36 Companies
in the Global Medical Care industry.

( Industry Median: 1.65 vs. MD: 1.05 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 0.72
MD's Price-to-Median-PS-Value is ranked higher than
81% of the 226 Companies
in the Global Medical Care industry.

( Industry Median: 1.10 vs. MD: 0.72 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
MD' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.22  Med: 1.01 Max: 3.6
Current: 0.72
0.22
3.6
Price-to-Peter-Lynch-Fair-Value 1.19
MD's Price-to-Peter-Lynch-Fair-Value is ranked higher than
73% of the 59 Companies
in the Global Medical Care industry.

( Industry Median: 2.11 vs. MD: 1.19 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
MD' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.09  Med: 1.31 Max: 3.93
Current: 1.19
0.09
3.93
Earnings Yield (Greenblatt) % 7.72
MD's Earnings Yield (Greenblatt) % is ranked higher than
83% of the 263 Companies
in the Global Medical Care industry.

( Industry Median: 3.84 vs. MD: 7.72 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
MD' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 5.9  Med: 8.4 Max: 19.1
Current: 7.72
5.9
19.1
Forward Rate of Return (Yacktman) % 20.47
MD's Forward Rate of Return (Yacktman) % is ranked higher than
80% of the 127 Companies
in the Global Medical Care industry.

( Industry Median: 10.98 vs. MD: 20.47 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
MD' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 14.7  Med: 19.4 Max: 25.5
Current: 20.47
14.7
25.5

More Statistics

Revenue (TTM) (Mil) $3,266.13
EPS (TTM) $ 3.36
Beta0.18
Short Percentage of Float8.23%
52-Week Range $53.80 - 76.04
Shares Outstanding (Mil)93.02

Analyst Estimate

Dec17 Dec18
Revenue (Mil $)
EPS ($) 3.66 4.00
EPS without NRI ($) 3.66 4.00
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for MD

Headlines

Articles On GuruFocus.com
A Deep Analysis of 6 Five-Star Companies Jun 02 2017 
Midland Announces the Discovery of Several New Gold Showings Up to 19.9 g/t Au on Heva Near the Cadi Jul 05 2016 
Midland and SOQUEM Identify New Targets on Casault and Resume Drilling Jun 23 2016 
Midland Announces Joint-Venture Agreement Near Eleonore Mine and Cheechoo Gold Discovery Jun 16 2016 
Midland Begins Prospecting and Stripping Program on Its Heva Gold Project Near the Cadillac Break May 26 2016 
Midland Resumes PGE Exploration in the Labrador Trough With Japan Oil, Gas and Metals National Corpo May 12 2016 
Midland Begins a Field Exploration Program on Its Willbob Gold Project in the Labrador Trough Apr 26 2016 
Midland Identifies New Prospective Ultramafic Complex and Discovers New Ni-Cu-PGE Zone on its Laflam Apr 14 2016 
Midland Increases its Land Position Near Sirios' Cheechoo Gold Discovery Apr 12 2016 
Midland Begins a First Drilling Program on La Peltrie Southeast of Detour Gold High Grade Gold Miner Mar 15 2016 

More From Other Websites
MEDNAX, Inc. breached its 50 day moving average in a Bearish Manner : MD-US : July 20, 2017 Jul 20 2017
MEDNAX 2017 Second Quarter Conference Call/Webcast Scheduled for Friday, July 28, 2017 Jul 18 2017
ETFs with exposure to MEDNAX, Inc. : July 14, 2017 Jul 14 2017
MEDNAX Radiology and vRad to Exhibit at AHRA 2017 Annual Meeting Jul 10 2017
MEDNAX, Inc. breached its 50 day moving average in a Bullish Manner : MD-US : June 22, 2017 Jun 22 2017
MEDNAX Announces Acquisition of Maternal-Fetal Medicine Practice in Tennessee Jun 20 2017
ETFs with exposure to MEDNAX, Inc. : June 19, 2017 Jun 19 2017
MEDNAX, Inc. :MD-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017 Jun 16 2017
Snap Has Shed an Astounding $13 Billion in Value and Now the Stock Is Trading Near Its IPO Price Jun 16 2017
4 Reasons to Stay Away from Mednax (MD) Now Jun 07 2017
A Deep Analysis of 6 Five-Star Companies Jun 02 2017
MEDNAX to Present at Upcoming Investor Conferences Jun 01 2017
What Makes MEDNAX (MD) a Strong Sell? May 31 2017
Edited Transcript of MD earnings conference call or presentation 4-May-17 2:00pm GMT May 08 2017
MEDNAX Reports First Quarter GAAP EPS of $0.59; Adjusted EPS of $0.75 May 04 2017
MEDNAX to Exhibit at Ambulatory Surgery Center Association 2017 Apr 21 2017
Mednax misses Street 1Q forecasts Apr 20 2017
MEDNAX Previews 2017 First Quarter Results Apr 20 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}